Pharmacokinetics of Laropiprant, a Selective Prostaglandin D2 Receptor 1 Antagonist, in Patients With Moderate Hepatic Impairment
暂无分享,去创建一个
J. Wagner | K. Lasseter | T. Marbury | A. Johnson‐Levonas | A. Nirula | E. Lai | Ying-hong Wang | N. Lunde | Fang Liu | Julie Ann Mabalot Luk | Julie Mabalot Luk | A. Johnson-Levonas | J. Luk